Current Studies

Last updated June 12, 2018

vials

Studies currently being conducted by the SIVS Clinical Trials Program (click on the ClinicalTrials.gov Identifier (NCT number) for more information
Recruiting

Current Studies - Recruiting

Active, Not Recruiting

Current Studies - Active, Not Recruiting

NCT02987972: A Phase II, Double-Blind, Randomized, Multicenter Trial to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar 13™ in Healthy Infants

Sponsor: Merck Sharp & Dohme Corp    

Principal Investigator: Richard Rupp, MD, Pediatric Clinic, Galveston Island East
Principal Investigator: Mark Wolffarth, MD, Pediatric Clinic, League City (Bay Colony)

NCT00000000: A Phase 1 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Live-Attenuated Tetravalent Dengue Vaccine (V181) in Flavivirus-Naïve and Flavivirus-Experienced Healthy Adults

Sponsor: Merck Sharp & Dohme Corp  Principal Investigator: Richard Rupp, MD

SIVS Globe logo 021618